Developer docs
API playgroundTry for free, no card

Search company profiles

Biotalys

Full company profile

uuid0000ei4

Namestring
Biotalys
Legal namestring
Biotalys NV
Websiteurl
biotalys.com
Company typeenum
Public
Founded yearint
2013
Descriptiontext

Biotalys NV is a Belgian AgTech company that develops protein-based biocontrol products for crop protection using its proprietary AGROBODY™ / AGROBODY Foundry™ 2.0 platform, an antibody-engineering technology that produces proteins with novel modes of action against fungal and insect pests. Founded in 2013 as a spin-off from VIB (Flanders Institute for Biotechnology) and headquartered in Ghent, Belgium, the company listed on Euronext Brussels in July 2021 (ticker: BTLS). Its lead product, the biofungicide EVOCA™, became the first protein-based biocontrol to receive full U.S. EPA registration in December 2025 and the first AGROBODY product to gain U.S. state registration (Florida) in April 2026; the next-generation commercial candidate EVOCA NG is targeted for U.S. registration in 2028-2029 and EU registration in 2029-2030. The pipeline extends to BioFun-6 (a higher-potency biofungicide candidate), a bioinsecticide co-developed with Syngenta (first research milestone achieved April 2026), and a post-harvest biofungicide developed with AgroFresh Solutions.

Biotalys is currently pre-commercial, with future revenue expected to come from direct enterprise sales to high-value fruit and vegetable growers (grapes, strawberries, tomatoes, cucurbits), supplemented by partnership-based commercialization: Syngenta for bioinsecticides, AgroFresh for post-harvest applications, and 21st.BIO for industrial-scale precision fermentation manufacturing. The company has reported a 2025 net loss of €15.8M (vs €13.2M in 2024), ended 2025 with €8.0M of cash, and in February 2026 cut approximately 30 jobs (~half its workforce) as part of a strategic refocus to save €20M by end-2028; it subsequently closed a €12.05M private placement in May 2026 to extend its cash runway.

Revenue mechanics today consist almost entirely of one-off R&D milestone payments (e.g., from Syngenta) and dilutive equity financings (€54.6M IPO in 2021, €15M in October 2024, €12.05M in May 2026), with no recurring product sales until EVOCA NG launches in 2028-2030. Customer segments are B2B enterprise growers and ag-input distributors in the U.S. (initially California and Florida) and the EU, with a combined target market estimated at approximately USD 1.1-1.2 billion. Backed by more than 25 patents, 700+ field trials across 10 countries, and recognition from the EPA, FRAC (new F10 class), IBMA (Bernard Blum Award 2024), and FoodTech 500 (#32 in 2025), the company is positioning AGROBODY-based biocontrols as a third category of crop protection that combines biological safety with chemical-like performance.

Short descriptiontext

Biotalys is a Belgian AgTech company developing protein-based biocontrol crop protection products using its proprietary AGROBODY™ platform, targeting fruit and vegetable growers through partnerships ahead of its first commercial launch in 2028-2030.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGhent, Belgium
HQ citystring
Ghent
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
protein-based biocontrols, crop protection products, agricultural biotechnology, biofungicide solutions, precision fermentation
Industry2 codes
PRIMARYEUAAAIAH
Bio-based Fertilizers, Soil Amendments & Biostimulants (Digestate-derived, biochar-based inputs)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code1 code
  • Pesticide and Other Agricultural Chemical Manufacturing325320
SIC code1 code
  • Agricultural Chemicals2870
Product category
Agricultural Biologicals / Crop Protection Biocontrols
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Pre-commercial / R&D stage
TypeSubscription Recurring
Description

Biotalys is pre-commercial; first revenue-generating product (EVOCA NG) targeted for 2028-2029 (U.S.) and 2029-2030 (EU). Reported 2025 net loss of €15.8M (vs €13.2M in 2024) and €8.0M cash at year-end 2025, with runway only until end of May 2026.

globenewswire.com
2Partnership milestone payments (e.g., Syngenta bioinsecticide collaboration)
TypeLicensing Royalties
Description

Biotalys receives milestone payments from R&D and co-development partners (e.g., Syngenta paid a first milestone in April 2026 for progress on a bioinsecticide using AGROBODY technology). Such payments are expected to be one-off milestone receipts tied to research and development progress.

globenewswire.com
3Future biocontrol product sales (EVOCA NG, post-harvest biofungicides)
TypeOne Time License
Description

Future revenue expected from direct product sales and/or partnership-based commercialization of EVOCA NG (targeted U.S. 2028-29, EU 2029-30) and post-harvest biofungicides developed with AgroFresh. Target market of approximately USD 1.1-1.2 billion combined U.S./EU.

globenewswire.com
4Post-harvest market product sales (with AgroFresh)
TypeOne Time License
Description

Future revenue from biological fungicides for post-harvest use to reduce food waste caused by fungal decay, co-developed with AgroFresh Solutions for global post-harvest supply chains.

growingproduce.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Pricing details1 tier
1Not publicly disclosed — pre-commercial stage; product pricing to be defined closer to commercial launch.
ModelOtherBilling cadenceOther
Notes

Quote-based / Not publicly disclosed. No published price list, tiers, or per-unit pricing for EVOCA / EVOCA NG.

biotalys.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1EVOCA
Description

Biotalys' first protein-based biofungicide, the first of its kind approved by the U.S. EPA (December 2025), targeting Botrytis and powdery mildew in high-value fruits and vegetables (grapes, tomatoes, strawberries, cucurbits) with a new FRAC F10 mode of action.

biotalys.com
+3 more records
Core offering1 text field

Biotalys develops and commercializes protein-based biocontrol products for crop protection using its proprietary AGROBODY™ technology platform. Its lead product EVOCA is a protein-based biofungicide that received full U.S. EPA registration in December 2025, targeting Botrytis and powdery mildew in high-value fruits and vegetables. The next-generation candidate EVOCA NG, the pipeline candidate BioFun-6, a bioinsecticide co-developed with Syngenta, and a postharvest biofungicide developed with AgroFresh extend the portfolio across the food value chain.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • BioFun-6 AGROBODY biocontrol candidate achieved same level of performance as EVOCA at significantly lower dosage rates (2/3 dose against Botrytis in grapes; 1/2 dose against powdery mildew in cucumber).
+4 more records
Product overview1 text field

Biotalys offers a unified platform-plus-product portfolio: the proprietary AGROBODY Foundry™ (currently in its AGROBODY 2.0 version) technology platform is the engine that rapidly generates novel protein-based biocontrols, while named product candidates are built on top of it. The first product derived from this platform is EVOCA™, a protein-based biofungicide that received full U.S. EPA registration in December 2025 and achieved its first U.S. state registration (Florida) in April 2026. The next-generation candidate EVOCA NG, the pipeline candidate BioFun-6, a bioinsecticide co-developed with Syngenta, and a postharvest biofungicide developed with AgroFresh are all built on the same AGROBODY platform and together target pre- and post-harvest crop protection across the food value chain.

Product and service6 records
1AGROBODY Foundry™
CategoryTechnology platform / R&D engine
Description

Proprietary protein-engineering technology platform that rapidly generates novel protein-based biocontrols with new modes of action, designed to combine multiple AGROBODY bioactives into a single product to expand optionality and lower resistance risk. Manufactured via industrial-scale precision fermentation.

2EVOCA™
CategoryBiofungicide (registered product)
Description

Biotalys' first protein-based biofungicide, targeting fungal pathogens (Botrytis and powdery mildew) in high-value crops such as grapes, tomatoes, strawberries, and cucurbits. Tested in over 700 field trials across 10 countries since 2017, with a clean residue profile (exempt from MRLs) suitable for spray rotation programs.

3EVOCA NG
CategoryNext-generation biofungicide (lead commercial candidate)
Description

Biotalys' next-generation biofungicide candidate, the lead commercial product, targeting a combined U.S. and European market estimated at around USD 1.1-1.2 billion. Production will be supported by the strategic partnership with 21st.BIO's precision fermentation platform.

4BioFun-6
CategoryNext-generation biofungicide (pipeline candidate)
Description

Next-generation biofungicide candidate in Biotalys' pipeline targeting Botrytis (grey mould) and powdery mildew in high-value fruits and vegetables. Demonstrated the same level of performance as EVOCA at significantly lower dosage rates, highlighting increased potency.

5Bioinsecticide (Syngenta collaboration)
CategoryBioinsecticide (pipeline candidate via partner)
Description

Bioinsecticide co-developed with Syngenta using Biotalys' AGROBODY technology to address key insect pests. Aims to address growing insect resistance and tightening regulatory constraints on conventional chemistries; Syngenta will lead future commercialization.

6Postharvest Biofungicide (AgroFresh collaboration)
CategoryPostharvest biological fungicide (pipeline candidate via partner)
Description

Biological fungicide for post-harvest use in food supply chains being developed in collaboration with AgroFresh Solutions to reduce food waste caused by fungal decay in high-value, highly perishable crops.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-07
Description

Strategic co-development partnership to develop a novel bioinsecticide using Biotalys' AGROBODY technology against key insect molecular targets. In April 2026 the partners achieved the first research milestone (promising in vitro results), with Syngenta making a milestone payment; both parties will proceed to the next research phase (in vivo testing on living organisms). Targets growing insect resistance and tightening regulatory constraints on conventional chemistries.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-09
Description

Biotalys continues its collaboration with the Gates Foundation despite the February 2026 restructuring; one of three named external collaborations alongside Syngenta and AgroFresh that the company plans to maintain.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-01-23
Description

Strategic partnership to leverage 21st.BIO's precision fermentation platform for large-scale, cost-competitive production of Biotalys' AGROBODY biocontrol products. Supports Biotalys' first commercial biofungicide EVOCA NG, targeting a combined U.S./EU market estimated at USD 1.1-1.2 billion, with regulatory submissions planned for 2028-29 in the U.S. and 2029-30 in the EU. Replaces Biotalys' prior collaboration with Novonesis, whose technology underpins 21st.BIO's platform.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-28
Description

Collaboration to develop sustainable biological fungicides for post-harvest use in food supply chains, providing environmentally friendly solutions to reduce food waste caused by fungal decay in fresh produce. Targets the highly perishable, high-value produce market.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2013-01-01
Description

Biotalys was founded in 2013 as a spin-off from VIB (Flanders Institute for Biotechnology). VIB participated as a shareholder in the May 2026 private placement, indicating an ongoing strategic and shareholder relationship.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in industrial enzymes and microbial biotechnology, with a substantial biocontrol and biopesticide portfolio (formerly Novozymes BioAg). Directly comparable as a broad incumbent in biological crop protection whose fermentation technology underpins Biotalys' new manufacturing partner 21st.BIO.

TypeBroad incumbent
Description

Global #1 crop protection company with both a large conventional chemistry portfolio and growing biologicals business. Both Biotalys' partner (bioinsecticide co-development) and a future competitor as a broad incumbent in the same high-value crop segments Biotalys targets.

TypeEmerging player
Description

U.S.-based agricultural technology company developing microbial seed treatments and biological crop inputs, with overlapping pre-commercial biological crop protection products and similar reliance on deep venture capital and partnership-driven commercialization.

TypeDirect peer
Description

Dutch global leader in biological crop protection with a broad portfolio of biopesticides and bumblebee pollination. Comparable as a focused biologicals company headquartered in the Netherlands, targeting the same high-value European fruit and vegetable growers with overlapping biocontrol offerings.

TypeOthers
Description

Global post-harvest solutions provider for fresh produce. Listed as Biotalys' partner for post-harvest biofungicides rather than a direct competitor; included because it represents the channel through which Biotalys' post-harvest pipeline reaches the global market and provides context on Biotalys' go-to-market dependencies.

TypeEmerging player
Description

U.S.-based agtech company developing microbial nitrogen-fixing crop nutrition products, with overlap in the protein-/microbe-based crop input category and similar partnership-driven go-to-market. Comparable as a venture-backed biological input developer with similar capital-intensity and partnership-led commercialization model.

TypeDirect peer
Description

U.S.-based agricultural biotechnology company developing biological crop protection products from microbial collections, with a similar pre-commercial / early-commercial model targeting high-value crop disease and pest control. Directly comparable as a venture-backed microbial/protein-based biocontrol developer competing for the same grower segments.

TypeBroad incumbent
Description

Global crop protection and seed major with extensive biologicals offerings alongside its chemistry portfolio. Comparable as a broad incumbent with overlapping biocontrol products (e.g., Serenade, Sonata) competing for the same high-value fruit and vegetable growers.

TypeEmerging player
Description

Argentina-based agricultural biotechnology company developing biological crop inputs including biofungicides and bioinsecticides, with comparable pre-commercial biological pipeline and Latin American commercialization footprint that complements Biotalys' U.S./EU focus.

TypeBroad incumbent
Description

Global crop protection major with both chemistry and biologicals portfolios, including biofungicides (e.g., Serifel) targeting Botrytis and powdery mildew in fruit and vegetables. Directly comparable as a broad incumbent competing in Biotalys' target disease-crop segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors18 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biotalys

Agricultural Biologicals / Crop Protection Biocontrolsbiotalys.com

Biotalys is a Belgian AgTech company developing protein-based biocontrol crop protection products using its proprietary AGROBODY™ platform, targeting fruit and vegetable growers through partnerships ahead of its first commercial launch in 2028-2030.

What Biotalys does

Biotalys NV is a Belgian AgTech company that develops protein-based biocontrol products for crop protection using its proprietary AGROBODY™ / AGROBODY Foundry™ 2.0 platform, an antibody-engineering technology that produces proteins with novel modes of action against fungal and insect pests. Founded in 2013 as a spin-off from VIB (Flanders Institute for Biotechnology) and headquartered in Ghent, Belgium, the company listed on Euronext Brussels in July 2021 (ticker: BTLS). Its lead product, the biofungicide EVOCA™, became the first protein-based biocontrol to receive full U.S. EPA registration in December 2025 and the first AGROBODY product to gain U.S. state registration (Florida) in April 2026; the next-generation commercial candidate EVOCA NG is targeted for U.S. registration in 2028-2029 and EU registration in 2029-2030. The pipeline extends to BioFun-6 (a higher-potency biofungicide candidate), a bioinsecticide co-developed with Syngenta (first research milestone achieved April 2026), and a post-harvest biofungicide developed with AgroFresh Solutions.

Biotalys is currently pre-commercial, with future revenue expected to come from direct enterprise sales to high-value fruit and vegetable growers (grapes, strawberries, tomatoes, cucurbits), supplemented by partnership-based commercialization: Syngenta for bioinsecticides, AgroFresh for post-harvest applications, and 21st.BIO for industrial-scale precision fermentation manufacturing. The company has reported a 2025 net loss of €15.8M (vs €13.2M in 2024), ended 2025 with €8.0M of cash, and in February 2026 cut approximately 30 jobs (~half its workforce) as part of a strategic refocus to save €20M by end-2028; it subsequently closed a €12.05M private placement in May 2026 to extend its cash runway.

Revenue mechanics today consist almost entirely of one-off R&D milestone payments (e.g., from Syngenta) and dilutive equity financings (€54.6M IPO in 2021, €15M in October 2024, €12.05M in May 2026), with no recurring product sales until EVOCA NG launches in 2028-2030. Customer segments are B2B enterprise growers and ag-input distributors in the U.S. (initially California and Florida) and the EU, with a combined target market estimated at approximately USD 1.1-1.2 billion. Backed by more than 25 patents, 700+ field trials across 10 countries, and recognition from the EPA, FRAC (new F10 class), IBMA (Bernard Blum Award 2024), and FoodTech 500 (#32 in 2025), the company is positioning AGROBODY-based biocontrols as a third category of crop protection that combines biological safety with chemical-like performance.

Biotalys firmographics

Firmographics
Name
Biotalys
Legal name
Biotalys NV
Website
https://biotalys.com
Company type
Public
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Biotalys is a Belgian AgTech company developing protein-based biocontrol crop protection products using its proprietary AGROBODY™ platform, targeting fruit and vegetable growers through partnerships ahead of its first commercial launch in 2028-2030.
Ownership category
akta.pro rank

Biotalys industry classification

Industry
Product category
Agricultural Biologicals / Crop Protection Biocontrols
NAICS
Pesticide and Other Agricultural Chemical Manufacturing (325320)
SIC
Agricultural Chemicals (2870)
akta.pro industry
PRIMARYEUAAAIAH
Bio-based Fertilizers, Soil Amendments & Biostimulants (Digestate-derived, biochar-based inputs)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Protein-based biocontrols
  • Crop protection products
  • Agricultural biotechnology
  • Biofungicide solutions
  • Precision fermentation

Where Biotalys is headquartered

Location

Headquarters

HQ city
Ghent
HQ country
Belgium
HQ region
Europe

Offices2 records

Markets served

Biotalys business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Pre-commercial / R&D stage: Biotalys is pre-commercial; first revenue-generating product (EVOCA NG) targeted for 2028-2029 (U.S.) and 2029-2030 (EU). Reported 2025 net loss of €15.8M (vs €13.2M in 2024) and €8.0M cash at year-end 2025, with runway only until end of May 2026.
  2. Partnership milestone payments (e.g., Syngenta bioinsecticide collaboration): Biotalys receives milestone payments from R&D and co-development partners (e.g., Syngenta paid a first milestone in April 2026 for progress on a bioinsecticide using AGROBODY technology). Such payments are expected to be one-off milestone receipts tied to research and development progress.
  3. Future biocontrol product sales (EVOCA NG, post-harvest biofungicides): Future revenue expected from direct product sales and/or partnership-based commercialization of EVOCA NG (targeted U.S. 2028-29, EU 2029-30) and post-harvest biofungicides developed with AgroFresh. Target market of approximately USD 1.1-1.2 billion combined U.S./EU.
  4. Post-harvest market product sales (with AgroFresh): Future revenue from biological fungicides for post-harvest use to reduce food waste caused by fungal decay, co-developed with AgroFresh Solutions for global post-harvest supply chains.

Pricing tiers

ModelBillingPrice
OtherOtherNot publicly disclosed — pre-commercial stage; product pricing to be defined closer to commercial launch.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Biotalys product offering

Product offering

Core offering

Biotalys develops and commercializes protein-based biocontrol products for crop protection using its proprietary AGROBODY™ technology platform. Its lead product EVOCA is a protein-based biofungicide that received full U.S. EPA registration in December 2025, targeting Botrytis and powdery mildew in high-value fruits and vegetables. The next-generation candidate EVOCA NG, the pipeline candidate BioFun-6, a bioinsecticide co-developed with Syngenta, and a postharvest biofungicide developed with AgroFresh extend the portfolio across the food value chain.

Product overview

Biotalys offers a unified platform-plus-product portfolio: the proprietary AGROBODY Foundry™ (currently in its AGROBODY 2.0 version) technology platform is the engine that rapidly generates novel protein-based biocontrols, while named product candidates are built on top of it. The first product derived from this platform is EVOCA™, a protein-based biofungicide that received full U.S. EPA registration in December 2025 and achieved its first U.S. state registration (Florida) in April 2026. The next-generation candidate EVOCA NG, the pipeline candidate BioFun-6, a bioinsecticide co-developed with Syngenta, and a postharvest biofungicide developed with AgroFresh are all built on the same AGROBODY platform and together target pre- and post-harvest crop protection across the food value chain.

Differentiator

Problem solved

Functional benefit

Brands

  • EVOCA: Biotalys' first protein-based biofungicide, the first of its kind approved by the U.S. EPA (December 2025), targeting Botrytis and powdery mildew in high-value fruits and vegetables (grapes, tomatoes, strawberries, cucurbits) with a new FRAC F10 mode of action.
  • EVOCA NG
  • AGROBODY Foundry
  • BioFun-6

Products and services

  • AGROBODY Foundry™ Proprietary protein-engineering technology platform that rapidly generates novel protein-based biocontrols with new modes of action, designed to combine multiple AGROBODY bioactives into a single product to expand optionality and lower resistance risk. Manufactured via industrial-scale precision fermentation.
  • EVOCA™ Biotalys' first protein-based biofungicide, targeting fungal pathogens (Botrytis and powdery mildew) in high-value crops such as grapes, tomatoes, strawberries, and cucurbits. Tested in over 700 field trials across 10 countries since 2017, with a clean residue profile (exempt from MRLs) suitable for spray rotation programs.
  • EVOCA NG Biotalys' next-generation biofungicide candidate, the lead commercial product, targeting a combined U.S. and European market estimated at around USD 1.1-1.2 billion. Production will be supported by the strategic partnership with 21st.BIO's precision fermentation platform.
  • BioFun-6 Next-generation biofungicide candidate in Biotalys' pipeline targeting Botrytis (grey mould) and powdery mildew in high-value fruits and vegetables. Demonstrated the same level of performance as EVOCA at significantly lower dosage rates, highlighting increased potency.
  • Bioinsecticide (Syngenta collaboration) Bioinsecticide co-developed with Syngenta using Biotalys' AGROBODY technology to address key insect pests. Aims to address growing insect resistance and tightening regulatory constraints on conventional chemistries; Syngenta will lead future commercialization.
  • Postharvest Biofungicide (AgroFresh collaboration) Biological fungicide for post-harvest use in food supply chains being developed in collaboration with AgroFresh Solutions to reduce food waste caused by fungal decay in high-value, highly perishable crops.

Quantifiable outcome

  • BioFun-6 AGROBODY biocontrol candidate achieved same level of performance as EVOCA at significantly lower dosage rates (2/3 dose against Botrytis in grapes; 1/2 dose against powdery mildew in cucumber).
  • +4 more outcomes

Companies that use Biotalys

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Biotalys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Biotalys partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship and core.

  • SyngentaflagshipStrategic or Co-development Partner · 7 April 2026Strategic co-development partnership to develop a novel bioinsecticide using Biotalys' AGROBODY technology against key insect molecular targets. In April 2026 the partners achieved the first research milestone (promising in vitro results), with Syngenta making a milestone payment; both parties will proceed to the next research phase (in vivo testing on living organisms). Targets growing insect resistance and tightening regulatory constraints on conventional chemistries.
  • Gates FoundationcoreStrategic or Co-development Partner · 9 February 2026Biotalys continues its collaboration with the Gates Foundation despite the February 2026 restructuring; one of three named external collaborations alongside Syngenta and AgroFresh that the company plans to maintain.
  • 21st.BIOflagshipStrategic or Co-development Partner · 23 January 2026Strategic partnership to leverage 21st.BIO's precision fermentation platform for large-scale, cost-competitive production of Biotalys' AGROBODY biocontrol products. Supports Biotalys' first commercial biofungicide EVOCA NG, targeting a combined U.S./EU market estimated at USD 1.1-1.2 billion, with regulatory submissions planned for 2028-29 in the U.S. and 2029-30 in the EU. Replaces Biotalys' prior collaboration with Novonesis, whose technology underpins 21st.BIO's platform.
  • AgroFresh SolutionscoreStrategic or Co-development Partner · 28 May 2025Collaboration to develop sustainable biological fungicides for post-harvest use in food supply chains, providing environmentally friendly solutions to reduce food waste caused by fungal decay in fresh produce. Targets the highly perishable, high-value produce market.
  • VIB (Flanders Institute for Biotechnology)flagshipStrategic or Co-development Partner · 1 January 2013Biotalys was founded in 2013 as a spin-off from VIB (Flanders Institute for Biotechnology). VIB participated as a shareholder in the May 2026 private placement, indicating an ongoing strategic and shareholder relationship.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Biotalys competitors and assessment

Company assessment

Broad incumbents

  • Novonesis (formerly Novozymes): Global leader in industrial enzymes and microbial biotechnology, with a substantial biocontrol and biopesticide portfolio (formerly Novozymes BioAg). Directly comparable as a broad incumbent in biological crop protection whose fermentation technology underpins Biotalys' new manufacturing partner 21st.BIO.
  • Syngenta: Global #1 crop protection company with both a large conventional chemistry portfolio and growing biologicals business. Both Biotalys' partner (bioinsecticide co-development) and a future competitor as a broad incumbent in the same high-value crop segments Biotalys targets.
  • Bayer Crop Science: Global crop protection and seed major with extensive biologicals offerings alongside its chemistry portfolio. Comparable as a broad incumbent with overlapping biocontrol products (e.g., Serenade, Sonata) competing for the same high-value fruit and vegetable growers.
  • BASF Agricultural Solutions: Global crop protection major with both chemistry and biologicals portfolios, including biofungicides (e.g., Serifel) targeting Botrytis and powdery mildew in fruit and vegetables. Directly comparable as a broad incumbent competing in Biotalys' target disease-crop segments.

Emerging players

  • Indigo Ag: U.S.-based agricultural technology company developing microbial seed treatments and biological crop inputs, with overlapping pre-commercial biological crop protection products and similar reliance on deep venture capital and partnership-driven commercialization.
  • Pivot Bio: U.S.-based agtech company developing microbial nitrogen-fixing crop nutrition products, with overlap in the protein-/microbe-based crop input category and similar partnership-driven go-to-market. Comparable as a venture-backed biological input developer with similar capital-intensity and partnership-led commercialization model.
  • Bioceres Crop Solutions: Argentina-based agricultural biotechnology company developing biological crop inputs including biofungicides and bioinsecticides, with comparable pre-commercial biological pipeline and Latin American commercialization footprint that complements Biotalys' U.S./EU focus.

Direct peers

  • Koppert Biological Systems: Dutch global leader in biological crop protection with a broad portfolio of biopesticides and bumblebee pollination. Comparable as a focused biologicals company headquartered in the Netherlands, targeting the same high-value European fruit and vegetable growers with overlapping biocontrol offerings.
  • AgBiome: U.S.-based agricultural biotechnology company developing biological crop protection products from microbial collections, with a similar pre-commercial / early-commercial model targeting high-value crop disease and pest control. Directly comparable as a venture-backed microbial/protein-based biocontrol developer competing for the same grower segments.

Others

  • AgroFresh Solutions: Global post-harvest solutions provider for fresh produce. Listed as Biotalys' partner for post-harvest biofungicides rather than a direct competitor; included because it represents the channel through which Biotalys' post-harvest pipeline reaches the global market and provides context on Biotalys' go-to-market dependencies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Biotalys social profiles

Digital presence

Biotalys compliance and trust

Trust signal

Compliance4 records

Biotalys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biotalys leadership team

Management profile

Number of profiles

Profiles11 records

Biotalys subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Biotalys funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biotalys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotalys

What does Biotalys do?

Biotalys develops and commercializes protein-based biocontrol products for crop protection using its proprietary AGROBODY™ technology platform. Its lead product EVOCA is a protein-based biofungicide that received full U.S. EPA registration in December 2025, targeting Botrytis and powdery mildew in high-value fruits and vegetables. The next-generation candidate EVOCA NG, the pipeline candidate BioFun-6, a bioinsecticide co-developed with Syngenta, and a postharvest biofungicide developed with AgroFresh extend the portfolio across the food value chain.

Is Biotalys a public or private company?

Biotalys is a public company. It is classified as public and is currently operating.

When was Biotalys founded?

Biotalys was founded in 2013. It employs 11 to 50 people.

Where is Biotalys based?

Biotalys is headquartered in Ghent, Belgium, in the Europe region.

How does Biotalys make money?

Four revenue lines are on record. Pre-commercial / R&D stage is the primary driver. The others are partnership milestone payments (e.g., Syngenta bioinsecticide collaboration), future biocontrol product sales (EVOCA NG, post-harvest biofungicides) and post-harvest market product sales (with AgroFresh).

Who are Biotalys's main competitors?

Broad incumbents on record are Novonesis (formerly Novozymes), Syngenta, Bayer Crop Science and BASF Agricultural Solutions. Emerging players are Indigo Ag, Pivot Bio and Bioceres Crop Solutions. Direct peers are Koppert Biological Systems and AgBiome. AgroFresh Solutions is listed as an others.

Does Biotalys have an API?

No public API is recorded for Biotalys.

What industry is Biotalys in?

Biotalys's product category is Agricultural Biologicals / Crop Protection Biocontrols. Its primary akta.pro industry code is EUAAAIAH, Bio-based Fertilizers, Soil Amendments & Biostimulants (Digestate-derived, biochar-based inputs), with a secondary code of EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives. Its NAICS code is 325320 and its SIC code is 2870.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialBiotalys Achieves Critical Manufacturing Milestone For First Commercial Biofungicide EVOCA® NGBiotalys completed a pilot production campaign for its first commercial biofungicide EVOCA NG, running five consecutive batches with 21st.BIO. The process achieved over 15-fold production efficiency improvement, and the company plans U.S. and E.U. registration in 2029.GlobeNewswireBiotalys Achieves Critical Manufacturing Milestone for First Commercial Biofungicide EVOCA® NGBiotalys completed a pilot production campaign for its first commercial biofungicide EVOCA NG, running five consecutive batches with 21st.BIO. The campaign achieved over a 15-fold improvement in production efficiency versus EVOCA, providing validation for product registration. EVOCA NG is planned for U.S. and E.U. registration in 2029.Business & FinancialBiotalys' First Commercial Biofungicide EVOCA® NG Approved For Large-Scale Commercial Field Trials In The NetherlandsBiotalys received Dutch regulatory approval to conduct large-scale field trials of its biofungicide EVOCA NG on up to 150 hectares of tomatoes, 150 hectares of cucumbers, and 50 hectares of strawberries. The trials will evaluate control of Botrytis and powdery mildew, with a planned European registration and launch in 2029.GlobeNewswireBiotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the NetherlandsBiotalys received Dutch regulatory approval to run large-scale trials of its biofungicide EVOCA NG on up to 150 hectares of tomatoes, 150 hectares of cucumbers, and 50 hectares of strawberries. The trials will evaluate control of Botrytis and powdery mildew, with a planned European registration and launch in 2029.YahooPress Release - Regulated InformationBiotalys NV disclosed its outstanding share capital and voting rights under Belgian law, totaling EUR 6,720,420.45 and 45,448,940 ordinary shares. The company also holds ESOP warrants and share units, with no convertible bonds or non-voting shares outstanding.The future of tradingBiotalys appoints Christine Berwaerts as audit committee chairBiotalys appointed Christine Berwaerts and Ioana Tudor as independent directors, expanding the board to seven members. Berwaerts, most recently CFO of Globachem, will chair the audit committee, replacing Laura Meyer, while Tudor replaces Patrick Van Beneden, effective Sept. 28, 2026.The future of tradingIndustry Leaders Christine Berwaerts and Ioana Tudor Join Biotalys’ Board as Independent DirectorsBiotalys appointed Christine Berwaerts and Ioana Tudor as independent directors, with Berwaerts also chairing the Audit Committee. The appointments take effect September 1 and 28, 2026, replacing two directors, and will be confirmed at the next shareholders meeting.YahooIndustry Leaders Christine Berwaerts and Ioana Tudor Join Biotalys’ Board as Independent DirectorsBiotalys appointed Christine Berwaerts and Ioana Tudor as independent directors, with Berwaerts also chairing the Audit Committee. The appointments take effect September 1 and September 28, 2026, replacing two departing directors, and will be confirmed at the next shareholders meeting.FinanzNachrichten.deBiotalys NV: Industry Leaders Christine Berwaerts and Ioana Tudor Join Biotalys' Board as Independent DirectorsBiotalys appointed Christine Berwaerts and Ioana Tudor as independent directors, with Berwaerts also chairing the Audit Committee. The appointments take effect September 1 and 28, 2026, replacing two departing directors. The board will then have seven members, including three women and four men.B2B MarketplaceBelgium's Biotalys wins California registration for EVOCA biofungicideCalifornia has granted state registration for Biotalys' EVOCA, its first protein-based biofungicide, confirming it met rigorous requirements for human health, environmental safety, and efficacy. This approval supports the development of EVOCA NG, which is expected to be the company's first commercial product for U.S. growers in 2029. The decision follows prior regulatory approvals by the U.S. Environmental Protection Agency and in Florida, strengthening Biotalys' foundation for future commercial presence.